Marina Konopleva, MD, PhD
Enriched profileProfessor of Oncology (Medical Oncology) and Molecular Pharmacology / Cell Biology; Director, Leukemia Program; Co-Director, Blood Cancer Institute (Translational Blood Cancer Institute), Montefiore Einstein Comprehensive Cancer Center; Miriam Mandel Faculty Scholar in Cancer Research · Albert Einstein College of Medicine
Marina Konopleva is Professor of Oncology (Medical Oncology) and Molecular Pharmacology / Cell Biology; Director, Leukemia Program; Co-Director, Blood Cancer Institute (Translational Blood Cancer Institute), Montefiore Einstein Comprehensive Cancer Center; Miriam Mandel Faculty Scholar in Cancer Research at Albert Einstein College of Medicine. OpenAlex indexes 2,096 publications with 71,749 citations (h-index 132); ClinicalTrials.gov lists 8 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Marina Konopleva is Professor of Oncology (Medical Oncology) and Molecular Pharmacology / Cell Biology at Albert Einstein College of Medicine / Montefiore Einstein Comprehensive Cancer Center. The public record shows 2,096 publications with 71,749 citations (h-index 132), centered on Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Acute Lymphoblastic Leukemia research. It also documents an investigator role on 8 registered clinical trials, 11 NIH-funded awards (2009–2023).
- Most recent indexed publication: 2026 · Blood
- Top research focus: Acute Myeloid Leukemia Research
- 8 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 147 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 746.
Clinical & industry
trials, payments and federal fundingNot shown. No U.S. clinical registration on file.
This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
Albert Einstein College of Medicine, Jack and Pearl Resnick Campus, 1300 Morris Park Avenue, Ullmann Building 915, Bronx, NY 10461
Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
- Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Sponsor: M.D. Anderson Cancer Center
- Oxidative Phosphorylation Inhibitor IACS-010759 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: M.D. Anderson Cancer Center
- LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: M.D. Anderson Cancer Center
Industry payments
Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →
NIH funding
Updated 27 Aug 2026
11 NIH research awards on record, funded 2009–2023 per NIH RePORTER. The latest:
- Interrogating Erythroid Differentiation and BCL-XL Axis in TP53-mutated Acute Myeloid Leukemia
Albert Einstein College of Medicine
FY2026$442,816R21CA299384 - Dual targeting of AML by BCL-2 inhibition and by CD123-directed NK engager/NK cell immune therapies
Albert Einstein College of Medicine
FY2026$431,970R21CA295428
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Long-Term Outcomes of Azacitidine, Venetoclax and Gilteritinib in Newly Diagnosed FLT3-Mutated AML.
Blood advances
Article2026 - Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic Leukemia.
Clinical cancer research
Article2026
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/marina-konopleva-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/marina-y-konopleva-md-phd-5bb559407
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - X / Twitter
x.com/mkonople
Mentions by others
where others cite or feature them- Facebook
facebook.com/EinsteinCollegeofMedicine/posts/marina-konopleva-md-phd-has-joined-forces-with-break-through-cancer-a-collaborat/962816475879208
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Facebook
facebook.com/montefioremedicalcenter/videos/marina-konopleva-md-phd-director-of-montefiore-einsteins-leukemia-program-and-co/2596339624066434
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Instagram
instagram.com/einsteinmed/p/DCSBTm-pcaf
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.montefioreeinstein.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.montefioreeinstein.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.montefioreeinstein.org ↗
- Postdoctoral Fellowship in Molecular Hematology
University of Texas MD Anderson Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.montefioreeinstein.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.montefioreeinstein.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.montefioreeinstein.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctors.montefioreeinstein.org ↗
Editorial & leadership roles
journal and society appointments- Director
Leukemia Program, Montefiore Einstein Comprehensive Cancer Center (MECCC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →montefioreeinstein.org ↗ - Co-Director
Blood Cancer Institute (Translational Blood Cancer Institute), MECCC
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.montefioreeinstein.org ↗ - Vice-Chair
Alliance for Clinical Trials in Oncology's Leukemia Committee for Correlative Science / Correlative Science Leader
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →montefioreeinsteinnow.org ↗
Awards & honors
honors on the public record- Elected Member
Association of American Physicians (AAP), inducted April 19, 2026 at joint AAP/ASCI meeting, Chicago
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →montefioreeinstein.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctors.montefioreeinstein.org ↗
- Otis W. and Pearl L. Walters Faculty Achievement Award in Clinical Research
MD Anderson Cancer Center
2020provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctors.montefioreeinstein.org ↗
Secondary affiliations
appointments beyond the home institution- Formerly Professor
Department of Leukemia, University of Texas MD Anderson Cancer Center (prior institution; departed ~July 2022 …
2022verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Member
Scientific Advisory Board, Science Translational Medicine (AAAS)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →science.org ↗
Media & interviews
press, podcasts and appearances- "Get to Know... Marina Konopleva, MD, PhD" -- profile feature
Blood Cancers Today
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bloodcancerstoday.com ↗ - OncoDaily Walk and Talk video interview with Marina Konopleva
hosted by Tatev Margaryan
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncodaily.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vjhemonc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Lipton, MD
Albert Einstein College of Medicine
Solomon Moshe, MD
Albert Einstein College of Medicine
Shlomo Shinnar, MD, PhD
Albert Einstein College of Medicine
Joshua Nosanchuk, MD
Albert Einstein College of Medicine